Back to News
Market Impact: 0.2
Merck Lifts Outlook on a Lower Tax Rate: Rapid Earnings Reaction
Source: fool.com
Corporate EarningsCompany Fundamentals
Merck's third-quarter sales rose 5% to about $18.1 billion, though roughly $550 million of the increase reflected customer purchase timing. Underlying growth was close to flat; the article notes newer drugs are scaling fast enough to offset generic losses.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment
MRK-0.15
More News
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days
- Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strength
- Nasdaq futures slide as mixed Big Tech results test AI trade
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks